4th Annual Investigator Initiated Studies Conference Set for May 19-20 in Dusseldorf, Germany

Ensuring ROI, Developing IIS Strategy, Protecting Intellectual Property Ownership Among New Session Topics. End Quote

(1888PressRelease) March 15, 2014 - Chicago, IL - For the fourth straight year, Q1 Productions will be hosting the European Investigator Initiated Studies Conference in Dusseldorf, Germany, providing attendees with the most valuable insight to the forecast of the IIS industry. This year's conference will offer nearly a dozen new session topics addressing the entire process of investigator research, from reviewing proposals and understanding how to best align research with the goals of the corporation to methods for closing out studies and handling publication data, all while maintaining strict adherence to legal and regulatory frameworks on an international playing field.

This year, the IIS Conference will include session topics covering the biggest concerns within the industry, such as monitoring multi-centered IISs, ensuring ROI, establishing a publication plan, as well as practical IIS case studies. Guest speakers, including Alexander Kostek of Pfizer, Joelle Rebetez of Actelion Pharmaceuticals, and Dominique Devos of Norgine will conduct in-depth and collaborative sessions and interactive panel discussions on several issues and challenges that are top-of-mind to medical and clinical affairs professionals within the healthcare space.

"This conference allows attendees to review the whole process in order to improve Return On Investment by working on strategy, outcomes, adherence to timelines and regulations while making sure not to take any sponsor responsibilities," said Dr. Dominique Devos, session speaker and Medical Advisor at Norgine.

By popular request, the conference, specially catering to pharmaceutical and medical device companies, will have more focus on legal aspects of external physician collaboration, a bigger focus on ROI, and more speakers from the pharmaceutical industry. The conference will offer an intimate setting to foster more peer-to-peer networking opportunities and promote discussion amongst industry professionals, as well as tailored sessions to accommodate pharmaceutical and medical device companies of all sizes.

For more information about the Investigator Initiated Studies Conference or to register for the meeting, please visit www.q1productions.com/euiis.

Media Contact:
Erica Abdnour
Q1 Productions
eabdnour ( @ ) q1productions dot com
(312) 955-0729

###

space

Other Related Press Releases